|
|
Prepublished online as a Blood First Edition Paper on September 19, 2002; DOI 10.1182/blood-2002-07-1957.
Previous Article | Table of Contents | Next Article 
Blood, 1 February 2003, Vol. 101, No. 3, pp. 1024-1029
IMMUNOBIOLOGY
IL-15 enhances survival and function of HIV-specific
CD8+ T cells
Yvonne M. Mueller,
Paul M. Bojczuk,
E. Scott Halstead,
Alfred H. J. Kim,
James Witek,
John D. Altman, and
Peter D. Katsikis
From the Department of Microbiology and Immunology and
Department of Medicine, Drexel University College of Medicine, Drexel
University, Philadelphia, PA; and Department of Microbiology and
Immunology, Emory University, Atlanta, GA.
HIV-specific CD8+ T cells are prone to undergo
apoptosis, and this may affect their ability to control HIV infection.
Because CD8-mediated immune responses play a key role in
controlling HIV infection, enhancing the survival and effector function
of HIV-specific CD8+ T cells may augment their ability to
control HIV virus. We show here that interleukin 15 (IL-15)
potently inhibits spontaneous and CD95/Fas-induced apoptosis of
HIV-specific CD8+ T cells. IL-15 inhibits apoptosis in both
CD45RA CD62L and
CD45RA+CD62L effector memory subpopulations
of these cells. Furthermore, IL-15 greatly enhances the survival of
HIV-specific CD8+ T cells in long-term cultures. Finally,
IL-15 directly enhances activation, interferon (IFN )
production, and direct ex vivo cytotoxicity of HIV-specific
CD8+ T cells. Thus, IL-15 potently enhances the survival
and effector function of HIV-specific CD8+ T cells and,
therefore, may prove useful in augmenting the antiviral function of
these cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. I. Kokaji, D. L. Hockley, and K. P. Kane
IL-15 Transpresentation Augments CD8+ T Cell Activation and Is Required for Optimal Recall Responses by Central Memory CD8+ T Cells
J. Immunol.,
April 1, 2008;
180(7):
4391 - 4401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Mueller, D. H. Do, S. R. Altork, C. M. Artlett, E. J. Gracely, C. D. Katsetos, A. Legido, F. Villinger, J. D. Altman, C. R. Brown, et al.
IL-15 Treatment during Acute Simian Immunodeficiency Virus (SIV) Infection Increases Viral Set Point and Accelerates Disease Progression despite the Induction of Stronger SIV-Specific CD8+ T Cell Responses
J. Immunol.,
January 1, 2008;
180(1):
350 - 360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Mueller, C. Petrovas, D. H. Do, S. R. Altork, T. Fischer-Smith, J. Rappaport, J. D. Altman, M. G. Lewis, and P. D. Katsikis
Early Establishment and Antigen Dependence of Simian Immunodeficiency Virus-Specific CD8+ T-Cell Defects
J. Virol.,
October 15, 2007;
81(20):
10861 - 10868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. G. Marcondes, T. H. Burdo, S. Sopper, S. Huitron-Resendiz, C. Lanigan, D. Watry, C. Flynn, M. Zandonatti, and H. S. Fox
Enrichment and Persistence of Virus-Specific CTL in the Brain of Simian Immunodeficiency Virus-Infected Monkeys Is Associated with a Unique Cytokine Environment
J. Immunol.,
May 1, 2007;
178(9):
5812 - 5819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hryniewicz, D. A. Price, M. Moniuszko, A. Boasso, Y. Edghill-Spano, S. M. West, D. Venzon, M. Vaccari, W.-P. Tsai, E. Tryniszewska, et al.
Interleukin-15 but Not Interleukin-7 Abrogates Vaccine-Induced Decrease in Virus Level in Simian Immunodeficiency Virusmac251-Infected Macaques
J. Immunol.,
March 15, 2007;
178(6):
3492 - 3504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Zimbwa, A. Milicic, J. Frater, T. J. Scriba, A. Willis, P. J. R. Goulder, T. Pillay, H. Gunthard, J. N. Weber, H.-T. Zhang, et al.
Precise Identification of a Human Immunodeficiency Virus Type 1 Antigen Processing Mutant
J. Virol.,
February 15, 2007;
81(4):
2031 - 2038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Stoklasek, K. S. Schluns, and L. Lefrancois
Combined IL-15/IL-15R{alpha} Immunotherapy Maximizes IL-15 Activity In Vivo
J. Immunol.,
November 1, 2006;
177(9):
6072 - 6080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Petrovas, J. P. Casazza, J. M. Brenchley, D. A. Price, E. Gostick, W. C. Adams, M. L. Precopio, T. Schacker, M. Roederer, D. C. Douek, et al.
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
J. Exp. Med.,
October 2, 2006;
203(10):
2281 - 2292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Combe, M. M. Moretto, J. D. Schwartzman, J. P. Gigley, D. J. Bzik, and I. A. Khan
Lack of IL-15 results in the suboptimal priming of CD4+ T cell response against an intracellular parasite
PNAS,
April 25, 2006;
103(17):
6635 - 6640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Snyder-Cappione, A. A. Divekar, G. M. Maupin, X. Jin, L. M. Demeter, and T. R. Mosmann
HIV-Specific Cytotoxic Cell Frequencies Measured Directly Ex Vivo by the Lysispot Assay Can Be Higher or Lower Than the Frequencies of IFN-{gamma}-Secreting Cells: Anti-HIV Cytotoxicity Is Not Generally Impaired Relative to Other Chronic Virus Responses
J. Immunol.,
February 15, 2006;
176(4):
2662 - 2668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M. Mueller, C. Petrovas, P. M. Bojczuk, I. D. Dimitriou, B. Beer, P. Silvera, F. Villinger, J. S. Cairns, E. J. Gracely, M. G. Lewis, et al.
Interleukin-15 Increases Effector Memory CD8+ T Cells and NK Cells in Simian Immunodeficiency Virus-Infected Macaques
J. Virol.,
April 15, 2005;
79(8):
4877 - 4885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Johnson
Murine Oviduct Epithelial Cell Cytokine Responses to Chlamydia muridarum Infection Include Interleukin-12-p70 Secretion
Infect. Immun.,
July 1, 2004;
72(7):
3951 - 3960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Lum, D. J. Schnepple, Z. Nie, J. Sanchez-Dardon, G. L. Mbisa, J. Mihowich, N. Hawley, S. Narayan, J. E. Kim, D. H. Lynch, et al.
Differential Effects of Interleukin-7 and Interleukin-15 on NK Cell Anti-Human Immunodeficiency Virus Activity
J. Virol.,
June 1, 2004;
78(11):
6033 - 6042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Gamadia, E. M. M. van Leeuwen, E. B. M. Remmerswaal, S.-L. Yong, S. Surachno, P. M. E. Wertheim-van Dillen, I. J. M. ten Berge, and R. A. W. van Lier
The Size and Phenotype of Virus-Specific T Cell Populations Is Determined by Repetitive Antigenic Stimulation and Environmental Cytokines
J. Immunol.,
May 15, 2004;
172(10):
6107 - 6114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Petrovas, Y. M. Mueller, I. D. Dimitriou, P. M. Bojczuk, K. C. Mounzer, J. Witek, J. D. Altman, and P. D. Katsikis
HIV-Specific CD8+ T Cells Exhibit Markedly Reduced Levels of Bcl-2 and Bcl-xL
J. Immunol.,
April 1, 2004;
172(7):
4444 - 4453.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |